CompletedInterventionalNot ApplicableLast updated Nov 8, 2024

FemaSeed LOCAL Artificial Insemination Trial

LOCAL: Prospective Multi-Center LOCALized Directional Insemination Trial for Artificial Insemination

Overview

ClinicalTrials.gov ID: NCT04968847
Lead Sponsor: Femasys Inc.INDUSTRY
Brief Summary: Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.
Study Type: Interventional

Status

Study Record Dates

NCT02593461Completed

Diafert® for Embryo Selection and Fertility Improvement

NCT02586272Completed

Diafert for Embryo Selection and Fertility Improvement

NCT02593513Completed

Diafert for Embryo Selection and Fertility Improvement (DESTINy)

NCT00745563Completed

Effects of Intra-uterine Slow-Release Insemination on Pregnancy Rate in Women Designated for Artificial Insemination

NCT06858111Recruiting

Fertilo In Vitro Research Study and Trial

NCT00816387Completed

Fallopian Tube Sperm Perfusion (FSP) Versus Intra-uterine Insemination (IUI) in Natural Cycle